.jpg?format=webp&quality=80&width=3840)
The study investigated the role of fatty acid (FA) metabolism in CD8+ T cells of rheumatoid arthritis (RA) patients. The researchers found that RA CD8+ T cells had altered FA metabolism and increased expression of FA transporters compared to healthy controls. RA patients who had a good response to methotrexate therapy showed increased expression of FA metabolism-related genes. Inhibiting FA metabolism impaired CD8+ T cell effector functions. The findings suggest that targeting FA metabolism could be a potential therapeutic strategy to control the proinflammatory profile of RA CD8+ T cells.
Like
Save
Share